Home / Drugs / Glyxambi (empagliflozin and linagliptin)

Glyxambi (empagliflozin and linagliptin)

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)

July 2016

WARNINGS AND PRECAUTIONS

Ketoacidosis (addition of the following sentence in first paragraph)

Fatal cases listed

About Tess Bryan

Tess Bryan is an influential Health & Travel blogger helping businesses worldwide to connect with their ideal audience and sharing great citizen journalism. Connect with her via Linkedin to share your story.

Check Also

Married to an Addict: Dealing with Addiction in a Marriage

For better or for worse were the vows you said, and those vows are tested …